The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Pearls & Myths: Experts Offer Advice & Dispel Myths

Pearls & Myths: Experts Offer Advice & Dispel Myths

February 25, 2020 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ATLANTA—A key sign of myositis can be mechanic’s hands on the thumb side of a patient’s index finger. Patients with giant cell arteritis (GCA) shouldn’t have to try prednisone before tocilizumab. Rituximab at fixed intervals is not essential for the remission of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis. In a session at the 2019 ACR/ARP Annual Meeting, two rheumatology experts shared these and other pearls of wisdom to help rheumatologists in the clinic, while also dispelling common myths.

You Might Also Like
  • Five Coding and Billing Myths that Can Hurt Your Practice
  • What Makes a Master Clinician? Dr. Sterling West Talks about His Career & Offers Advice for Future Rheumatologists
  • Experts Offer Management Tips, from Contracts to Credentials to Audits
Explore This Issue
March 2020
Also By This Author
  • EULAR 2014: Cardiac Involvement in Rheumatic Diseases

Cautioning that new discoveries may make “today’s pearls tomorrow’s myths,” John Stone, MD, director of clinical rheumatology at Massachusetts General Hospital, Boston, offered the following myth-busting observations and tips.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Myth: Temporal artery biopsy is the gold standard for the diagnosis of GCA.

“With modern imaging and the incredible techniques we have with PET [positron-emission tomography], ultrasound, CTA [computed tomography angiogram] and MRA [magnetic resonance angiogram], we know patients who have large vessel involvement and may not have temporal involvement at all. And there are many reasons temporal artery biopsies can be negative,” Dr. Stone said. “The key diagnostic test in a patient with possible GCA is the history. A carefully taken history is the rheumatologist’s scalpel.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pearl: A dry cough can be a symptom of occult GCA. “For patients who are over the age of 50 with any complaint above the head and neck who have signs of inflammation, GCA needs to be considered,” he said.

Myth: Tocilizumab should be reserved for GCA patients for whom prednisone has failed. Dr. Stone pointed to the GIACTA trial results, which showed the prednisone-only group sustained remission in only 14% or 18% of GCA cases, depending on the study group, compared with more than 50% of GCA cases for the tocilizumab groups.1

“It’s crazy to think about using a drug that’s going to fail most of the time—and is toxic—as the only starting approach to treating this [disease],” Dr. Stone said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pearl: Tongue ulcers in GCA occur on the lateral portion of the mid-tongue. The same goes for granulomatosis with polyangiitis (GPA).

Myth: Patients with ANCA-associated vasculitis require fixed intervals of B-cell depletion to maintain remission. Spacing treatment out at increasingly longer intervals—first four months, then six months and then eight months, for example—can accomplish the same goal, Dr. Stone said.

GPA & Beyond
Pearl: GPA can cause a facial droop. This effect occurs because the seventh cranial nerve runs through the middle ear space. When patients with GPA get otitis media and granulomatous inflammation in the middle ear, the nerve can compress, leading to a facial droop, he said.

Pages: 1 2 3 | Single Page

Filed Under: 2019 ACR/ARP Annual Meeting, Career Development, Professional Topics Tagged With: 2019 ACR/ARP Annual Meeting, Career, rheumatology, tipsIssue: March 2020

You Might Also Like:
  • Five Coding and Billing Myths that Can Hurt Your Practice
  • What Makes a Master Clinician? Dr. Sterling West Talks about His Career & Offers Advice for Future Rheumatologists
  • Experts Offer Management Tips, from Contracts to Credentials to Audits
  • Trial Data Reveals the Limitations of Steroids in Giant Cell Arteritis Therapy

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)